PAFAH1B3 and cancer: Receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic value of PAFAH1B3 in various human cancers and found that it had moderate accuracy (AUC > 0.75) in predicting BLCA, BRCA, CHOL, COAD, ESCA, GBM, HNSC, KICH, KIRP, LAML, LGG, LIHC, LUAD, LUSC, OV, PAAD, PRAD, THCA, THYM, and UCS (Figures 3A–F) and high accuracy (AUC > 0.90) in predicting BRCA, CHOL, COAD, KICH, LAML, LUAD, LUSC, OV, PAAD, READ, SKCM, STAD, TGCT, THCA, THYM, and UCS.